Free Trial
NASDAQ:KRRO

Korro Bio (KRRO) Stock Price, News & Analysis

Korro Bio logo
$16.00 +0.14 (+0.88%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$15.68 -0.32 (-2.03%)
As of 08/8/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Korro Bio Stock (NASDAQ:KRRO)

Key Stats

Today's Range
$15.69
$16.89
50-Day Range
$10.80
$16.85
52-Week Range
$10.29
$98.00
Volume
87,100 shs
Average Volume
121,590 shs
Market Capitalization
$150.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$102.43
Consensus Rating
Buy

Company Overview

Korro Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

KRRO MarketRank™: 

Korro Bio scored higher than 28% of companies evaluated by MarketBeat, and ranked 800th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Korro Bio has received a consensus rating of Buy. The company's average rating score is 3.29, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Korro Bio has only been the subject of 3 research reports in the past 90 days.

  • Read more about Korro Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Korro Bio are expected to decrease in the coming year, from ($9.52) to ($10.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Korro Bio is -1.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Korro Bio is -1.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Korro Bio has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Korro Bio's valuation and earnings.
  • Percentage of Shares Shorted

    20.04% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 7.8.
  • Change versus previous month

    Short interest in Korro Bio has recently increased by 8.91%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Korro Bio does not currently pay a dividend.

  • Dividend Growth

    Korro Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    20.04% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 7.8.
  • Change versus previous month

    Short interest in Korro Bio has recently increased by 8.91%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Korro Bio this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for KRRO on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Korro Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Korro Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of Korro Bio is held by insiders.

  • Percentage Held by Institutions

    Only 13.18% of the stock of Korro Bio is held by institutions.

  • Read more about Korro Bio's insider trading history.
Receive KRRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter.

KRRO Stock News Headlines

Korro Bio, Inc. (KRRO) - Yahoo Finance
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
Korro to Participate in Upcoming Investor Conferences
Korro Bio to Cut 20% of Workforce
Korro Bio to Cut 20% of Workforce
See More Headlines

KRRO Stock Analysis - Frequently Asked Questions

Korro Bio's stock was trading at $38.07 at the start of the year. Since then, KRRO stock has decreased by 58.0% and is now trading at $16.00.

Korro Bio, Inc. (NASDAQ:KRRO) posted its earnings results on Wednesday, May, 7th. The company reported ($2.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.60) by $0.11. The business had revenue of $2.55 million for the quarter, compared to analysts' expectations of $0.13 million.

Top institutional investors of Korro Bio include Geode Capital Management LLC (1.65%) and AlphaQuest LLC (0.29%). Insiders that own company stock include Venture Opportunity Fund Atlas, David L Lucchino and Vineet Agarwal.
View institutional ownership trends
.

Shares of KRRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Korro Bio investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/07/2025
Today
8/10/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KRRO
Previous Symbol
NASDAQ:KRRO
CIK
1703647
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

High Price Target
$180.00
Low Price Target
$25.00
Potential Upside/Downside
+540.2%
Consensus Rating
Buy
Rating Score (0-4)
3.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($9.44)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.58 million
Net Margins
N/A
Pretax Margin
-1,810.56%
Return on Equity
-51.64%
Return on Assets
-37.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.41
Quick Ratio
9.41

Sales & Book Value

Annual Sales
$4.82 million
Price / Sales
31.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.12 per share
Price / Book
0.93

Miscellaneous

Outstanding Shares
9,391,000
Free Float
8,959,000
Market Cap
$150.26 million
Optionable
No Data
Beta
2.51

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:KRRO) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners